Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by jayjay2020on Nov 20, 2018 8:01pm

94 Views

Post# 29002441

RE:RE:RE:RE:RE:RE:RE:RE:Poll

Themanfromcomo wrote: @jayjay.... Tell that to the people who bought at 24.75.

tell HEXO people that they lost money when they bought the high. I mean what us your point? My point is clear the Molson deal added about 10-15% value to HEXO as company. That is nothing. And when HEXO has to dilute to support financing the R&D for the deal.it will be less of a gain to HEXO. The deal.only helped Molson get into the MJ space with little money and little risk.

Bullboard Posts

Increasing summer travel could see these airline stocks soar